Esports Entertainment Group to Ring the Nasdaq Stock Market Closing Bell on July 21
BIRKIRKARA, Malta, July 21, 2020 (GLOBE NEWSWIRE) — Esports Entertainment Group, Inc. (NasdaqCM: GMBL, GMBLW) (or the “Company”), a licensed […]
Capital City Bank Group, Inc. Reports Second Quarter 2020 Results
TALLAHASSEE, Fla., July 21, 2020 (GLOBE NEWSWIRE) — Capital City Bank Group, Inc. (NASDAQ: CCBG) today reported net income of […]
First Commercial Product Using Antares Pharma’s Multi-Dose Pen Platform Launches in Europe
EWING, N.J., July 21, 2020 (GLOBE NEWSWIRE) — Antares Pharma, Inc. (NASDAQ: ATRS) (“Antares”) (“the Company”), a pharmaceutical technology company, […]
TSX News -
Troilus Completes Royalty Buy-Back and Continues to Consolidate Claims in Frôtet-Evans Greenstone Belt; Expands Land Position by 23,000 Hectares
TORONTO, July 21, 2020 (GLOBE NEWSWIRE) — Troilus Gold Corp. (TSX: TLG) (OTCQB: CHXMF) (“Troilus” or the “Company”) is pleased […]
Velocity Receives Positive Drill Results from Rozino Gold Project, Southeast Bulgaria
Near-surface highlights include:Drill hole RDD-191; 23.2m @ 0.95 g/t gold, incl. 10.0m @ 1.78 g/t goldDrill hole RDD-183; 21.8m @ […]
Intrepid Announces Early Paydown of Series C Senior Notes
DENVER, CO, July 21, 2020 (GLOBE NEWSWIRE) — Intrepid Potash Inc. (NYSE:IPI) (“Intrepid”) announced today it paid down its Series […]
Murphy USA Inc. Reports Second Quarter 2020 Results
EL DORADO, Ark., July 21, 2020 (GLOBE NEWSWIRE) — Murphy USA Inc. (NYSE: MUSA), a leading marketer of retail motor […]
Rapid Dose Therapeutics and McMaster University Initiate QuickStrip™ COVID-19 Vaccine Research With Immediate Impact
BURLINGTON, Ontario, July 21, 2020 (GLOBE NEWSWIRE) — Rapid Dose Therapeutics Corp. (“RDT” or the “Company”) (CSE: DOSE), a Canadian Life […]
REPEAT – Ready, Set, Smoke! Taat Herb Co. Publishes Footage from Beyond Tobacco™ Production Run
Through production vendor Hempacco, Taat has completed a test production run of Beyond Tobacco™ cigarettes which has confirmed their suitability […]
Lexicon Pharmaceuticals Announces Topline Phase 3 Data From Four Phase 3 Sotagliflozin Studies in Type 2 Diabetes
THE WOODLANDS, Texas, July 21, 2020 (GLOBE NEWSWIRE) — Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX), today announced topline data from four […]
